PatientsForce's new public campaign — see it at the exhibition hall
AI-translated from the Chinese original · editorially reviewed

PatientsForce, part of Media-WIND Health Group (MWHG), has launched an outdoor campaign for its Patient Support Program to raise awareness of patient support and benefit management. Facing gaps in coverage for new medicines, PatientsForce offers a socially innovative solution — a campaign that underscores the company's commitment to ensuring patients can access the medicines they need and to expanding what patient benefits can be.
Using the large exterior window display at PatientsForce headquarters in Taipei World Trade Center Exhibition Hall 1 — where exhibition foot traffic exceeds a million visitors a year — PatientsForce poses an important question: "New drugs, paid out of pocket — why so expensive?" In an era of rapid advances in medical technology, beyond the continued growth of national and private insurance to expand payment capacity, could there be more innovative market mechanisms to meet individual patients' immediate clinical needs for new medicines?
Founded in 2008, Media-WIND Health Group (MWHG) has grown from patient-focused medical communications and marketing into pharmaceutical e-commerce and Patient Support Program management. In recent years it has invested in AI solutions for smart healthcare and doctor–patient communication, offering financing for self-paid specialty medicines and value-based companion care services to improve access to complete medical care. Alongside personalized support and professional patient benefit program management, the company has a team of outstanding medical communication and service experts supporting a wide range of public health communication projects.
"We are dedicated to optimizing market-based solutions for new drug launches and patient access," said Hsiang-Hsin Chang, General Manager of Media-WIND Health Group (MWHG). "Our goal is to make sure patients receive full information and support on their medicines — and easing the out-of-pocket burden of new drugs is one part of that."
─ PatientsForce, Media-WIND Health Group (MWHG)

